Description
Update of the Belgian guidelines for HER2 testing in breast cancer
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Update of the Belgian guidelines for HER2 testing in breast cancer
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart -
Article: Calendar of events
€2.42 Add to cart -
Article: Highlights in respiratory oncology
€2.42 Add to cart
